Charlotte Hobbs

Professor

University of Mississippi Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Charlotte Hobbs is a faculty member at the University of Mississippi Medical Center in the United States. Her research primarily focuses on pediatric infectious diseases, with recent publications examining COVID-19 immunity, vaccine effectiveness, and the implications of viral infections in children. She has also explored genetic factors related to fat oxidation in HIV-infected youth and the epidemiology of strongyloidiasis in the U.S.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (3)

Janet Hume

Assistant Professor

University of Minnesota Medical School

UNITED STATES

View details

Saul Hymes

Associate Professor of Pediatrics

Albany Medical Center

UNITED STATES

View details

Kari Wellnitz

Clinical Associate Professor

The University of Iowa Roy J and Lucille A Carver College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Charlotte Hobbs

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A Description of COVID-19-Directed Therapy in Children Admitted to US Intensive Care Units 2020.

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.

BNT162b2 Protection against the Omicron Variant in Children and Adolescents.

Hospitalizations Associated with Strongyloidiasis in the United States, 2003-2018.

Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants.

Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.

Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.

Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents.

Collaborators (3)

Janet Hume

Saul Hymes

Kari Wellnitz

Make your next move.